Above all, quality standards must be maintained. This is a view upheld by the CMO's Committee looking at skill mix in the NHSBSP. How are these standards to be maintained and our targets achieved, against a background of possible Government intention to expand the target population, by increasing the screening age limit up to 70 years and a yearly population increase? …
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.